Huixin Pharmaceutical added vitamin D3 project in 2023. 2023-02-10
Jiangsu Yuanda Yue Xian Pharmaceutical Co., Ltd. newly built acetylcysteine project. 2023-02-10
Anhui Zhixin Biochemical Co., Ltd. Project with an annual output of 200 tons of avermectin, 150 tons of decadialdehyde 650 tons of β -ionone. 2023-02-10
Shouguang Golden Corn Development Co., Ltd. started construction of the lysine project with an annual output of 200,000 tons. 2023-02-10
Yunnan Zewei Pharmaceutical Co., Ltd. Reconstruction expansion project of steroid hormone raw materials (progesterone, BA, methylprednisolone, difucol, etc.) 2023-01-12
Anhui Baker Pharmaceutical Co., Ltd. newly built Monapinavir Lopinavir API project 2023-01-12
The net profit of East Asia pharmaceutical industry in 2022 was 104 million yuan, the production sales of 7-ANCA increased significantly. 2023-01-12
Anhui Fengyuan Likang Pharmaceutical invested in rebuilding the new valine project. 2023-01-12
Announcement of commissioning time of isosorbide project of Shandong Tianli Pharmaceutical Co., Ltd. (as of March 31, 2023) 2023-01-12
Shandong Xiaowei Biotechnology invested in a new project of bio-fermentation to produce bio-based L- malic acid succinic acid. 2023-01-12
Yunnan Zewei Pharmaceutical Co., Ltd. expands the project of steroid hormone raw materials, namely, diprogesterone, vitamin D3, vitamin D2 nicotine. 2023-01-12
With a total investment of 620 million yuan, Yunnan Pingbian natural astaxanthin big health industry integration development project started construction. 2023-01-12
BASFs expanded propionic acid production capacity will be put into production in the fourth quarter of 2023. 2023-01-12
Anhui Huaheng Biological Company launched a new product "inositol" 2023-01-06
Inner Mongolia Jindawei Pharmaceutical Co., Ltd. rebuilt expanded new projects such as adenosylmethionine, glutathione phosphatidylserine. 2023-01-06
Hendi Pharmaceutical Industry: At present, the companys production capacity of ibuprofen is 3500 tons/year. 2022-12-30
Jiheng Pharmaceutical Co., Ltd.: Paracetamol raw materials are suspended for export are all supplied to China. 2022-12-30
Guo Bang Pharmaceutical Co., Ltd. expanded its technical transformation project with an annual output of 1,171 tons of raw materials intermediates (Norfloxacin, etc.) 2022-12-30
The latest quotation of main products (vitamin B12, coenzyme Q10, etc.) of Yuxing Biological Group on December 29th 2022-12-30
Haocheng Bio invested 150 million yuan to build a new lactose peptide, protein powder inositol project (Phase I). 2022-12-30
Jiangxi Haiwen Biotechnology Co., Ltd. invested in a new project with an annual output of 10,000 tons of vitamin B3. 2022-12-30
Latest news: NHU Vitamin E production line will be discontinued from January 1, 2023. 2022-12-30
Brother Haining Vitamin K3 Base of Science Technology plans to stop production overhaul at the end of December 2022. 2022-12-30
Four major vitamin K3 enterprises in China announced the end of the year to stop production overhaul. 2022-12-30
Latest news: Amoxicillin Ampicillin API manufacturers raise their external prices. 2022-12-16
Brother Haining Vitamin K3 Base of Science Technology plans to stop production overhaul at the end of December 2022. 2022-12-15
The vitamin C production line of DSM Jiangshan Pharmaceutical will be reduced from December 5th. 2022-12-08
The demfor cold medicines has increased greatly, the crude drugs of antipyretic analgesic drugs are tight expensive. 2022-11-27
DSM is affected by the energy cost, the production base of vitamin A will stop production. 2022-11-27
DSM recently issued a notice on the discontinuation of vitamin A the reduction of vitamin E production. 2022-11-27
Sichuan Bohaodas 10,000-ton enzymatic inositol production line project will be completed by the end of 2022. 2022-11-27
Some manufacturers stopped reporting signing vitamin A vitamin E from November 23rd until the end of the year. 2022-11-27
共
4532 个 页次:
9 /
142 页
32 个/页
首页 上一页 下一页 尾页
转到:
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
Our Advantages of Reports
①All reports written by ourselves ②All data having original sources ③Information is the latest ④Continuous historical data ⑤Objective analysis and remark
Purchase Flow of Reports
①Confirm purchase (If necessary sign the contract) ②Transfer payment to company's bank account ③After accepting payment we email the report to clients (PDF format) ④Send the invoice
Bank account
①Beneficiary's Name:Beijing orientbit technology ltd ②Beneficiary's Account No.:110060239018002127366 ③Name of bank:Bank of Communications Beijing Branch,Fuwai Sub-Branch ④Address of bank:NO7,FUWAISTREET,XICHENG DISTRICT,BEIJING,CHINA SWIFT CODE:COMMCNSHBJG